April 27, 2026

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential with a 106.10% Return on Equity

As one of the leading titans in the global healthcare sector, Amgen Inc. (NASDAQ: AMGN) has consistently demonstrated its prowess in developing and delivering innovative human therapeutics. With a market..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 21.44% Potential Upside in the Biopharma Giant

Gilead Sciences, Inc. (NASDAQ: GILD) remains a heavyweight in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $161.85 billion, this biopharmaceutical giant continues..

UnitedHealth Group (UNH) Stock Analysis: Discover the 8.78% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, is garnering significant attention from investors, driven by its robust market position and promising analyst ratings. As a leading..

Merck & Co., Inc. (MRK) Stock Analysis: A 15.94% Potential Upside with Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK), a cornerstone in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic partnerships. With a market capitalization of $276.38..

Ilika opens a new route to market with Brompton battery project

Ilika’s new Brompton partnership gives investors a clearer view of how Goliath batteries could find commercial traction beyond their core automotive pathway...

Genflow Biosciences (LON:GENF) and the Breakthrough Promise of Gene Therapy in Childhood Blindness

Genflow Biosciences highlights gene therapy innovation after a child’s sight improves following treatment for rare inherited blindness...

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by..

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

Zotefoams outlines 2025 financial performance and sets 2026 AGM

Zotefoams plc has released its 2025 Annual Report, detailing full-year financial performance and management commentary, including reviews from the Chair, Group CEO and CFO...

Tirupati Graphite rebrands to Total Graphite, restarts Madagascar operations

The company has announced a corporate name change to Total Graphite Plc alongside the resumption of production and shipments at its Vatomina project in Madagascar, following recent fundraising and operational..
Search

Funds

April 27, 2026

Ilika opens a new route to market with Brompton battery project

Ilika’s new Brompton partnership gives investors a clearer view of how Goliath batteries could find commercial traction beyond their core automotive pathway...

Genflow Biosciences (LON:GENF) and the Breakthrough Promise of Gene Therapy in Childhood Blindness

Genflow Biosciences highlights gene therapy innovation after a child’s sight improves following treatment for rare inherited blindness...

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership...

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

Zotefoams outlines 2025 financial performance and sets 2026 AGM

Zotefoams plc has released its 2025 Annual Report, detailing full-year financial performance and management commentary, including reviews from the Chair, Group CEO and CFO...

Tirupati Graphite rebrands to Total Graphite, restarts Madagascar operations

The company has announced a corporate name change to Total Graphite Plc alongside the resumption of production and shipments at its Vatomina project in Madagascar, following recent fundraising and operational preparations...
Search

Funds

April 27, 2026

FTSE 100

Funds